The changing landscape of hormonal therapy in castration-resistant prostate cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
The changing landscape of hormonal therapy in castration-resistant prostate cancer ; volume:01 ; number:02 ; year:2012 ; pages:53-55
South Asian journal of cancer ; 01, Heft 02 (2012), 53-55
- Beteiligte Personen und Organisationen
-
Dongre, Amol
Prabhash, Kumar
Noronha, Vanita
- DOI
-
10.4103/2278-330X.103707
- URN
-
urn:nbn:de:101:1-2021022618591138975675
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dongre, Amol
- Prabhash, Kumar
- Noronha, Vanita
Ähnliche Objekte (12)
Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line – Indian consensus statement update
Chronic myeloid leukemia data from India
Confusion worse confounded
Promoting of Oncology Training and Education in India: Lessons from our unique oncology continuing medical education project
Thyroid cancer in Gardner’s syndrome: Case report and review of literature
Geriatric oncology: The need of the hour
Carcinomatous meningitis in non-small cell lung cancer: Palliation with intrathecal treatment
An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast–ovarian cancer syndrome
Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience
Lung cancer in the Indian subcontinent
Comparison of postoperative complications in advanced head and neck cancer patients receiving neoadjuvant chemotherapy followed by surgery versus surgery alone
Advances in hormonal therapies for hormone naïve and castration-resistant prostate cancers with or without previous chemotherapy
Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line – Indian consensus statement update
Chronic myeloid leukemia data from India
Confusion worse confounded
Promoting of Oncology Training and Education in India: Lessons from our unique oncology continuing medical education project
Thyroid cancer in Gardner’s syndrome: Case report and review of literature
Geriatric oncology: The need of the hour
Carcinomatous meningitis in non-small cell lung cancer: Palliation with intrathecal treatment
An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast–ovarian cancer syndrome
Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience
Lung cancer in the Indian subcontinent
Comparison of postoperative complications in advanced head and neck cancer patients receiving neoadjuvant chemotherapy followed by surgery versus surgery alone
Advances in hormonal therapies for hormone naïve and castration-resistant prostate cancers with or without previous chemotherapy
Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line – Indian consensus statement update
Chronic myeloid leukemia data from India
Confusion worse confounded
Promoting of Oncology Training and Education in India: Lessons from our unique oncology continuing medical education project
Thyroid cancer in Gardner’s syndrome: Case report and review of literature
Geriatric oncology: The need of the hour
Carcinomatous meningitis in non-small cell lung cancer: Palliation with intrathecal treatment
An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast–ovarian cancer syndrome
Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience
Lung cancer in the Indian subcontinent
Comparison of postoperative complications in advanced head and neck cancer patients receiving neoadjuvant chemotherapy followed by surgery versus surgery alone